Administration

Navigator wisdom

The UroGPO team joined the AUS team in Chicago for its APC Champs 2.0 program. It was impressive how quickly AUS has integrated APC therapies for its patient population of men with prostate cancer.

The passion and excitement of the navigator and administrator staff was palpable as they push their extended urology team to optimize intra-practice patient referrals. Kristyn Minetti (APC nurse navigator), Eliza Roque (manager), Donna Erickson (director of ancillary services) and Linda Mathis have been a driving force in AUS’ APC success.  In speaking with Kristyn, she was eager to standardize the APC referral trigger and gain 100% compliance from team members.  Additionally, she was excited to begin leveraging data platforms for optimal patient identification and monitoring.  From the UroGPO perspective, these components of an APC specialist model have been key to unlocking patient treatment consistency and superior practice economics.

Notable initiatives in the works include APC marketing via patient brochures and web, defined scanning, monitoring and treatment protocols, and established APC success metrics. We look forward to seeing further success from this APC team.

UroGPO’s uTrack portal: Know your widgets

The uTrack portal has a wealth of information to optimize your member contract performance. Take advantage of the UroGPO product widgets so you don’t miss contract thresholds at quarter end.

The uTrack portal is your tool for accessing and assessing your active member contracts. uTrack pulls data for monitoring performance toward volume, tier or market share goals (depending on contract requirements), as well as subsequent rebate performance.

uTrack access can be granted to multiple practice members, and we encourage you to share performance goal information with relevant practice team members. Successful planning will prevent end-of-quarter rushes and allow for more consistent patient scheduling and manageable workloads.

We have activated three new widgets for the Endo portfolio of urology products with quarterly goals, Xiaflex, Aveed and Valstar.  Review your data to plan for quarter-end.

SaveSave

SaveSave

SaveSave

SaveSave

Clinical hot topics * Powered by UroToday

GU cancers

FDA approves adjuvant treatment for RCC patients following nephrectomy

The FDA granted an additional indication for sunitinib on Nov. 16, 2017. This oral agent was approved for the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma following nephrectomy. Approval was based on disease-free survival data from the S-TRAC study. (Data published December 2016, NEJM.).

Full prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021938s033lbl.pdf.

Is RADAR on your radar? 

The RADAR and RADAR 2 working groups have developed consensus opinions for monitoring and managing men with advanced prostate cancer. These recommendations address when to image patients in order to proactively find M1 disease, as well as evaluate how to optimally layer therapies with unique mechanisms of action.

Urology

BPH: Expert commentary on the minimally invasive Prostatic Urethral Lift (PUL)

The Prostatic Urethral Lift (PUL) has been shown to rapidly and durably relieve men’s lower urinary tract symptoms – LUTS – secondary to benign prostatic hyperplasia (BPH) with minimal side effects.

Claus Roehrborn, M.D., professor and chair of the Department of Urology UT Southwestern Medical Center in Dallas and co-principal investigator for the L.I.F.T. clinical program, detailed findings from the largest, prospective, multicenter, randomized, controlled trial on the minimally invasive PUL to date at the 2017 American Urological Association annual meeting in Boston, May 12-16.

 

 

 

 

SaveSave

SaveSave

SaveSaveSaveSave

SaveSave

Member profile

The UroGPO team recently attended an APC Champs program at Arkansas Urology in Little Rock, Arkansas. While already a well-oiled machine, the Arkansas team brought opportunities for improvement to the table and sparked some great conversations. Scot Davis’ leadership and vision is evident, and we congratulate the group members on their APC success, as well as the recent completion of their 12,500-square-foot surgery center. And that brings us to our member profile of the month.

Scot Davis – CEO Arkansas Urology

Scot Davis joined Arkansas Urology as CEO in May 2013. With more than 20 years in physician practice management serving in a variety of executive roles, he has developed an expertise in physician recruitment, joint-venture arrangements, compensation modeling and operational efficiency.

Scot is not just focusing on next week, next month or even next year. Instead, he continues to lay a strategic path for sustained long-term success. He highlighted the group’s Strategic Retreat as a venue for creating this collective vision and focus for the group.

For example, its Advanced Prostate Cancer Clinic was borne from a commitment made at the Strategic Retreat of 2015. He encourages an open mind for considering strategic projects and is motivated to avoid stagnation. To identify future initiatives, Scot advises, “Look at all opportunities, learn what to quickly pass on, make a decision (once, not five times) and execute the plan.”

Scot says he takes the MBS approach to managing — Management By Scot.

  • Hire really good people.
  • Tell them what you want.
  • Get out of their way.
  • Reward and recognize.

This approach has had a tangible impact on morale, camaraderie and productivity at the practice.

As part of UroGPO’s Men’s Health Initiatives, UroGPO will be tapping into Scot’s experience and expertise. He says the term “men’s health” can be myopically interpreted as relating solely to urology-related conditions. Instead, his vision for what great can look like involves holistic integration of other specialists, with the urology practice serving as quarterback. Similar to other initiatives, Scot called out the need for Men’s Health pathways that lead to more comprehensive care, as well as collaboration with other like-minded urology practices to achieve a sustainable and consistent treatment plan for men.

We thank Scot for sharing his words of wisdom and congratulate him and his team on their success. As part of our commitment to maintaining a strong UroGPO community and fostering open dialogue, we will continue to bring you member profiles. Knowing more about your urology colleagues will allow you to network, communicate and bring best practices home to your groups.

Learn more about Scott at http://www.arkansasurology.com/physicians-and-staff/e-scot-davis.

SaveSave

Message from the CEO

On behalf of the UroGPO team, we hope that you’ve had a happy Thanksgiving weekend. As busy as we all are, it is great to enjoy time with family and friends and spend time away from the office, and we hope you had a chance to do so. That being said, we look forward to crossing paths with our member practices soon. We genuinely enjoy the work that brings us to your practices. We learn about your practice opportunities and tackle your business challenges, but we also get to know you better. UroGPO is thankful for your partnership.

David Coury, CEO

Practice administrator

2018 340B reform: 2018 Medicare Annual Payment Rules finalized for outpatient hospital departments.

 

IOD practices’ Fraud, Waste and Abuse Training requirement

Groups with an in-office dispensing program are required to have dispensary employees complete and attest to an annual Fraud, Waste and Abuse Training. If not yet completed, make sure to do so by the end of the year. UroGPO will be glad to assist practices that have not yet updated their NCPDP and Third Party Station profiles with their attestation requirements.

Any entity that dispenses medications to Medicare Part D patients, that is contracted with Prescription Benefit Managers (PBMs), is required to train all dispensary employees on Fraud, Waste and Abuse and General Compliance. Each dispensary employee must complete the training and the practice must attest that all employees are in compliance.

You can meet these requirements in one of two ways.

  • First, have all dispensary employees (techs, billers, dispensing physicians, purchaser, manager, etc. – anyone who is part of the dispensary process who may be able to detect FWA) go online via the CMS Medicare Learning Network (MLN), take both the FWA & General Compliance courses and produce the certificates of completion at the end of each program.
  • Alternatively, each dispensary employee can attest to having read and understood the material by simply creating a one-page document on your practice letterhead with a statement indicating that “the below listed employees attest to having completed the CMS Fraud, Waste and Abuse and General Compliance programs.” List the employee names on the letter and have them sign and date next to their printed names. This document will serve as your annual attestation. This training is required before you begin dispensing, as well as annually.